<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Rev Bras Ter Intensiva</journal-id><journal-id journal-id-type="iso-abbrev">Rev Bras Ter Intensiva</journal-id><journal-id journal-id-type="publisher-id">Rev Bras Ter Intensiva</journal-id><journal-title-group><journal-title>Revista Brasileira de Terapia Intensiva</journal-title></journal-title-group><issn pub-type="ppub">0103-507X</issn><issn pub-type="epub">1982-4335</issn><publisher><publisher-name>Associa&#x000e7;&#x000e3;o Brasileira de Medicina intensiva</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23917935</article-id><article-id pub-id-type="pmc">4031818</article-id><article-id pub-id-type="doi">10.1590/S0103-507X2012000400013</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>The use of 2% chlorhexidine gel and toothbrushing for oral hygiene of
patients receiving mechanical ventilation: effects on ventilator-associated
pneumonia</article-title><trans-title-group xml:lang="pt"><trans-title>Uso de clorexidina 2% gel e escova&#x000e7;&#x000e3;o mec&#x000e2;nica na higiene bucal de
pacientes sob ventila&#x000e7;&#x000e3;o mec&#x000e2;nica: efeitos na pneumonia associada a
ventilador</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Meinberg</surname><given-names>Maria Cristina de Avila</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cheade</surname><given-names>Maria de F&#x000e1;tima Meinberg</given-names></name></contrib><contrib contrib-type="author"><name><surname>Miranda</surname><given-names>Amanda Lucia Dias</given-names></name></contrib><contrib contrib-type="author"><name><surname>Fachini</surname><given-names>Marcela Mascaro</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lobo</surname><given-names>Suzana Margareth</given-names></name><xref ref-type="corresp" rid="c01"/></contrib><aff>Intensive Care Division, Hospital de Base de S&#x000e3;o Jos&#x000e9; do Rio Preto - S&#x000e3;o Jos&#x000e9; do
Rio Preto (SP), Brazil. </aff></contrib-group><author-notes><corresp id="c01"><bold>Corresponding author:</bold> Suzana Margareth Lobo. Servi&#x000e7;o de Terapia
Intensiva - Hospital de Base. Faculdade de Medicina de S&#x000e3;o Jos&#x000e9; do Rio Preto. Avenida
Brigadeiro Faria de Lima, 5.416. Zip Code: 15090-000 - S&#x000e3;o Jos&#x000e9; do Rio Preto (SP),
Brasil. E-mail: suzana-<email>lobo@uol.com.br</email></corresp></author-notes><pub-date pub-type="ppub"><season>Oct-Dec</season><year>2012</year></pub-date><volume>24</volume><issue>4</issue><fpage>369</fpage><lpage>374</lpage><history><date date-type="received"><day>27</day><month>3</month><year>2012</year></date><date date-type="accepted"><day>28</day><month>9</month><year>2012</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited. </license-p></license></permissions><abstract><sec><title>Objective</title><p>To evaluate the effects of oral chlorhexidine hygiene with toothbrushing on the
rate of ventilator-associated pneumonia in a mixed population of critically ill
patients under prolonged mechanical ventilation. </p></sec><sec><title>Methods</title><p>Prospective, randomized, and placebo-controlled pilot study. Patients who were
receiving mechanical ventilation, had been admitted less than 24 hours prior, and
were anticipated to require mechanical ventilation for more than 72 hours were
included in the study. The patients were randomly divided into one of the
following groups: chlorhexidine hygiene with toothbrushing or a placebo group (gel
with the same color and consistency and toothbrushing). </p></sec><sec><title>Results</title><p>The planned interim analysis was conducted using 52 patients, and the study was
terminated prematurely. In total, 28 patients were included in the chlorhexidine /
toothbrushing group, and 24 patients were included in the placebo group.
Ventilator-associated pneumonia occurred in 45.8% of the placebo group and in
64.3% of the chlorhexidine hygiene with toothbrushing group (RR=1.4; 95%
CI=0.83-2.34; p=0.29). </p></sec><sec><title>Conclusion</title><p>Because the study was terminated due to futility, it was not possible to evaluate
the impact of oral hygiene using 2% chlorhexidine and toothbrushing on the
incidence of ventilator-associated pneumonia in this heterogeneous population of
critical patients receiving long-term mechanical ventilation, and no beneficial
effect was observed for this intervention.</p></sec></abstract><trans-abstract xml:lang="pt"><sec><title>Objetivo</title><p>Avaliar os efeitos da higiene bucal com clorexidina 2% e escova&#x000e7;&#x000e3;o mec&#x000e2;nica sobre
a taxa de pneumonia associada a ventilador em uma popula&#x000e7;&#x000e3;o mista de pacientes sob
ventila&#x000e7;&#x000e3;o mec&#x000e2;nica prolongada. </p></sec><sec><title>M&#x000e9;todos</title><p>Estudo piloto prospectivo, aleat&#x000f3;rio e placebo-controlado. Foram inclu&#x000ed;dos
pacientes sob ventila&#x000e7;&#x000e3;o mec&#x000e2;nica, com menos de 24 horas de interna&#x000e7;&#x000e3;o e cuja
perspectiva de dura&#x000e7;&#x000e3;o da ventila&#x000e7;&#x000e3;o mec&#x000e2;nica era a de um per&#x000ed;odo &#x0003c;72 horas. Os
pacientes foram randomizados para o grupo clorexidina (gel com clorexidina a 2%) e
escova&#x000e7;&#x000e3;o mec&#x000e2;nica ou grupo placebo (gel da mesma colora&#x000e7;&#x000e3;o e consist&#x000ea;ncia e
escova&#x000e7;&#x000e3;o mec&#x000e2;nica) na higiene bucal. </p></sec><sec><title>Resultados</title><p>A an&#x000e1;lise interina planejada foi realizada quando 52 pacientes foram inclu&#x000ed;dos, e
o estudo foi interrompido precocemente. Um total de 28 pacientes foi inclu&#x000ed;do no
grupo clorexidina/escova&#x000e7;&#x000e3;o mec&#x000e2;nica e 24 no grupo placebo. As taxas de pneumonia
associada a ventilador foram de 45,8% no grupo placebo e de 64,3% no grupo
clorexidine/escova&#x000e7;&#x000e3;o mec&#x000e2;nica (RR=1,4; IC95%=0,83-2,34;p=0,29). </p></sec><sec><title>Conclus&#x000e3;o</title><p>Devido a interrup&#x000e7;&#x000e3;o precoce por futilidade, n&#x000e3;o foi poss&#x000ed;vel avaliar o impacto do
uso de clorexidina a 2% e escova&#x000e7;&#x000e3;o mec&#x000e2;nica na higiene bucal na incid&#x000ea;ncia de
pneumonia associada a ventilador nessa popula&#x000e7;&#x000e3;o heterog&#x000ea;nea de pacientes cr&#x000ed;ticos
sob ventila&#x000e7;&#x000e3;o mec&#x000e2;nica prolongada, n&#x000e3;o tendo sido evidenciado nenhum efeito
ben&#x000e9;fico dessa interven&#x000e7;&#x000e3;o.</p></sec></trans-abstract><kwd-group><kwd>Pneumonia, ventilator-associated</kwd><kwd>Oral hygiene</kwd><kwd>Chlorhexidine/administration &#x00026; dosage</kwd><kwd>Placebos</kwd><kwd>Manual brushing</kwd><kwd>Intensive care units</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are the most
common nosocomial infections among patients in intensive care units (ICUs). The risk of
occurrence is 1% to 3% for each day a patient receives mechanical
ventilation.<sup>(<xref rid="r01" ref-type="bibr">1</xref>)</sup> The incidence
varies from 7% to 40%, depending on such factors as the study population, ICU type, and
diagnostic criteria.<sup>(<xref rid="r02" ref-type="bibr">2</xref>)</sup> Respiratory
infections greatly affect hospitals financially, due to prolonged hospital stays and
requirements for broad-spectrum antibiotics and additional exams.<sup>(<xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r03" ref-type="bibr">3</xref>)</sup>
</p><p>The main mechanism for pathogens' entry into the lower respiratory tract of severely ill
patients is aspiration of the contents of the oropharynx or secretions that accumulate
above the endotracheal tube cuff, which are colonized by oral microorganisms from dental
cavities, biofilms, and periodontal disease pockets.<sup>(<xref rid="r04" ref-type="bibr">4</xref>)</sup> Although controversial, sinuses an\d the stomach may
also be reservoirs for bacteria that can colonize the oropharynx and trachea.<sup>(<xref rid="r02" ref-type="bibr">2</xref>)</sup> For pneumonia to occur, pathogens must
overcome respiratory-system defense mechanisms: mechanical (cough reflex, glottic
reflex, and the mucociliary system); humoral (antibodies and the complement system); and
cellular (polymorphonuclear leukocytes, macrophages, and lymphocytes).<sup>(<xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r04" ref-type="bibr">4</xref>)</sup>
</p><p>Modifiable risk factors are possible targets for interventions in pneumonia prevention.
Among the greatest risk factors for nosocomial pneumonia are endotracheal intubation and
mechanical ventilation, which cause a 3- to 21-fold increase in the risk of developing
nosocomial pneumonia.<sup>(<xref rid="r05" ref-type="bibr">5</xref>)</sup> Several
strategies have been recommended and applied in clinical practice, such sedation
protocols with more interactive patients, daily interruption of sedation, maintenance of
a semi-recumbent position (30 to 45 degrees), and oral hygiene.<sup>(<xref rid="r01" ref-type="bibr">1</xref>)</sup>
</p><p>Oral hygiene is considered crucial for preventing pneumonia; however, there are no clear
guidelines for how oral hygiene should be performed, leading to different hygienic
practices in different clinical settings. Chlorhexidine is used as an oral antiseptic
for reducing dental plaque in critical-care and ICU patients.<sup>(<xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r06" ref-type="bibr">6</xref>-<xref rid="r09" ref-type="bibr">9</xref>)</sup> This measure may reduce the pathogenic load in the
plaque and, potentially, reduce nosocomial pneumonia rates.<sup>(<xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r09" ref-type="bibr">9</xref>-<xref rid="r12" ref-type="bibr">12</xref>)</sup> The use of 0.12% chlorhexidine decreases the occurrence
of HAP in patients undergoing cardiac surgery.<sup>(<xref rid="r06" ref-type="bibr">6</xref>)</sup> A meta-analysis of 7 studies concluded that the occurrence of VAP
decreased almost 30%, but this effect appears to have been more significant in
populations of patients undergoing heart surgery.<sup>(<xref rid="r13" ref-type="bibr">13</xref>)</sup> The aim of the present study was to evaluate the effects of an
oral hygiene protocol (consisting of 2% chlorhexidine and manual brushing) in a
heterogeneous population of ICU patients on the VAP incidence, duration of mechanical
ventilation, and lengths of the patients' ICU and hospital stays.</p></sec><sec sec-type="methods"><title>METHODS</title><p>The present investigation was a prospective, randomized, and placebo-controlled pilot
study approved by the Research Ethics Committee at the Faculdade de Medicina de S&#x000e3;o Jos&#x000e9;
do Rio Preto. Free and Informed Consent Forms (FICF) were obtained from the patients'
next of kin. The study was conducted between July 2007 and December 2009 in the
Clinical-Surgery ICU (23 beds) at the Hospital de Base de S&#x000e3;o Jos&#x000e9; do Rio Preto.</p><p>Inclusion criteria for the study were as follows: over 18 years old, receiving
mechanical ventilation for less than 24 hours after admission, and expected to require
ventilation for more than 72 hours. Exclusion criteria were aspiration pneumonia,
tracheostomy, pregnancy, and immunosuppression.</p><p>The nursing team was trained on the importance of oral hygiene and on how to use the
experimental protocol, which consisted of manual cleaning with a toothbrush (Bitufo,
Itupeva, Sao Paulo, Brazil) and application of the gel to the entire oral cavity 4 times
per day until the given patient was released from the ICU.</p><p>After obtaining the FICF, randomization was conducted using sealed envelopes in blocks
of 10. The patients were randomly assigned to the chlorhexidine group (2% chlorhexidine
gel) or to the placebo group (gel with the same color and consistency). Only the
pharmacist responsible for preparing the solutions and for the randomization process
knew the contents of the distributed gel tubes.</p><p>Dental exams were performed 3 or 4 times at 48-hour intervals, depending on the
patient's length of stay in the ICU. The dental clinical examination involved
evaluations for the presence of bacterial plaque. The oral condition was classified
using the L&#x000f6;e and Silness index that was modified for recording plaque deposits (plaque
index) on a scale of 0 to 3.<sup>(<xref rid="r14" ref-type="bibr">14</xref>)</sup> The
scale was as follows: 0, no plaque; 1, plaque observed after removal with a periodontal
probe from the gingival margin of the tooth crown; 2, clinically visible plaque; 3,
extensive plaque.</p><p>The primary outcome in this study was the occurrence of VAP, which was determined by the
presence of a new radiological pulmonary infiltrate on chest X-rays after 48 hours in
the ICU, plus 2 or more of the following clinical or laboratory signs: axillary
temperature &#x02265;38&#x000ba;C or &#x02264;36&#x000ba;C, leukocytes &#x0003e;11,000/mm<sup>3</sup> or leukopenia
&#x0003c;4,000/mm<sup>3</sup>, or the presence of purulent tracheal secretions.</p><sec><title>Statistical analysis</title><p>The estimated incidence of VAP was 30% in the placebo group and 15% in the study
group with a calculated sample size of 98 patients in each group, a statistical power
of 80%, and a significance level of 0.05. The first formal interim analysis was
planned to occur when 50% of the patients were included. The analysis was performed
when 52 patients were included, and the study was suspended due to futility.</p><p>Student's t-test was conducted to compare 2 groups of continuous variables with
normal distributions, and the Mann-Whitney test was used when the variables were not
normally distributed. The incidence of the outcomes was evaluated using relative risk
(RR) with a 95% confidence interval (95% CI). Statistical significance was set at
p&#x0003c;0.05.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>In total, 2,774 patients were admitted to the ICU. Of these patients, 87 patients were
evaluated in the study, 33 of which were excluded because they did not meet the
inclusion and exclusion criteria, namely, receiving mechanical ventilation for &#x0003c;72
hours, missing the 24-hour window for inclusion, or release or death before 72 hours
(<xref ref-type="fig" rid="f01">Figure 1</xref>). Fifty-two patients (28 patients in
the 2% chlorhexidine/toothbrushing group and 24 patients in the placebo group) were
included in the study.</p><fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Distribution of the study population. VAP - ventilator associated pneumonia.</p></caption><graphic xlink:href="rbti-24-04-0369-g01"/></fig><p><xref ref-type="table" rid="t01">Table 1</xref> lists the demographic data and
characteristics of the patients. The study participants ranged from 18 to 81 years of
age. The majority were surgical patients - 89% of the chlorhexidine group and 79% of the
control group. The most common admission diagnosis was trauma, accounting for 48% of the
patients.</p><table-wrap id="t01" orientation="portrait" position="float"><label>Table 1</label><caption><p>Characteristics of patients in the placebo and 2% chlorhexidine/toothbrushing
groups</p></caption><table frame="hsides" rules="groups"><thead><tr><td colspan="2" rowspan="1"><bold>Variables</bold></td><td align="center" rowspan="1" colspan="1"><bold>Placebo</bold></td><td align="center" rowspan="1" colspan="1"><bold>Chlorhexidine</bold></td><td align="center" rowspan="1" colspan="1"><bold>p value</bold></td></tr></thead><tbody><tr><td colspan="2" rowspan="1">Number of patients</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td colspan="2" rowspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">41.0&#x000b1;19.0</td><td align="center" rowspan="1" colspan="1">40.1&#x000b1;14.6</td><td align="center" rowspan="1" colspan="1">0.84</td></tr><tr><td colspan="2" rowspan="1">APACHE II</td><td align="center" rowspan="1" colspan="1">16.7&#x000b1;6.8</td><td align="center" rowspan="1" colspan="1">17.9&#x000b1;4.5</td><td align="center" rowspan="1" colspan="1">0.45</td></tr><tr><td colspan="2" rowspan="1">Diagnosis</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;</td><td rowspan="1" colspan="1">Clinical</td><td align="center" rowspan="1" colspan="1">5(20.8)</td><td align="center" rowspan="1" colspan="1">3(10.7)</td><td align="center" rowspan="1" colspan="1">0.32</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">Surgical</td><td align="center" rowspan="1" colspan="1">19(79.2)</td><td align="center" rowspan="1" colspan="1">25(89.3)</td><td align="center" rowspan="1" colspan="1">0.53</td></tr><tr><td colspan="2" rowspan="1">Clinical condition</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">Trauma</td><td align="center" rowspan="1" colspan="1">12(50.0)</td><td align="center" rowspan="1" colspan="1">13(46.4)</td><td align="center" rowspan="1" colspan="1">0.98</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">Stroke</td><td align="center" rowspan="1" colspan="1">3(12.5)</td><td align="center" rowspan="1" colspan="1">4(14.2)</td><td align="center" rowspan="1" colspan="1">0.81</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">Postoperative complications</td><td align="center" rowspan="1" colspan="1">3(12.5)</td><td align="center" rowspan="1" colspan="1">6(21.4)</td><td align="center" rowspan="1" colspan="1">0.62</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">Guillain-Barr&#x000e9; syndrome</td><td align="center" rowspan="1" colspan="1">1(4.1)</td><td align="center" rowspan="1" colspan="1">0(0.0)</td><td align="center" rowspan="1" colspan="1">0.97</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">Rectal neoplasia</td><td align="center" rowspan="1" colspan="1">2(8.3)</td><td align="center" rowspan="1" colspan="1">1(3.5)</td><td align="center" rowspan="1" colspan="1">0.92</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">Septic shock</td><td align="center" rowspan="1" colspan="1">2(8.3)</td><td align="center" rowspan="1" colspan="1">2(7.1)</td><td align="center" rowspan="1" colspan="1">0.71</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">Acute pulmonary edema</td><td align="center" rowspan="1" colspan="1">1(4.1)</td><td align="center" rowspan="1" colspan="1">1(3.5)</td><td align="center" rowspan="1" colspan="1">0.54</td></tr></tbody></table><table-wrap-foot><fn><p>APACHE II - Acute Physiology and Chronic Health Evaluation. Results are
expressed as the mean &#x000b1; standard deviation or the number (%).</p></fn></table-wrap-foot></table-wrap><p>Eleven patients (45.8%) in the placebo group and 18 patients (64.3%) in the 2%
chlorhexidine/toothbrushing group developed VAP (RR=1.4; 95% CI=0.83-2.34; p=0.29).</p><p>The average length of mechanical ventilation was 6 days in the placebo group and 8.5
days in the 2% chlorhexidine/toothbrushing group (p=0.17) (<xref ref-type="table" rid="t02">Table 2</xref>). More patients in the placebo group had shorter mechanical
ventilation times compared with the chlorhexidine group (50% <italic>versus</italic>
17.8%; p=0.03). The average length of stay in the ICU for the studied patients was 12
days for the 2% chlorhexidine/manual brushing group and 11 days for the placebo group
(p=0.36). The mortality rate was 46.5% in the 2% chlorhexidine/toothbrushing group and
37.5% in the placebo group (RR=1.24; 95%CI=0.64-2.37; p=0.07).</p><table-wrap id="t02" orientation="portrait" position="float"><label>Table 2</label><caption><p>Outcomes of the placebo and 2% chlorhexidine/toothbrushing groups</p></caption><table frame="hsides" rules="groups"><thead><tr><td colspan="2" rowspan="1"><bold>Variables</bold></td><td align="center" rowspan="1" colspan="1"><bold>Placebo N(%)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Chlorhexidine N(%)</bold></td><td align="center" rowspan="1" colspan="1"><bold>p value</bold></td></tr></thead><tbody><tr><td colspan="2" rowspan="1">VAP rate</td><td align="center" rowspan="1" colspan="1">11(45.8)</td><td align="center" rowspan="1" colspan="1">18(64.3)</td><td align="center" rowspan="1" colspan="1">0.29</td></tr><tr><td colspan="2" rowspan="1">Microbiologically confirmed VAP rate</td><td align="center" rowspan="1" colspan="1">8(72.7)</td><td align="center" rowspan="1" colspan="1">12(66.6)</td><td align="center" rowspan="1" colspan="1">0.86</td></tr><tr><td colspan="2" rowspan="1">Duration of intubation (days)</td><td align="center" rowspan="1" colspan="1">6 [4-12.7]</td><td align="center" rowspan="1" colspan="1">8.5 [7.3-14.7]</td><td align="center" rowspan="1" colspan="1">0.17</td></tr><tr><td colspan="2" rowspan="1">Duration of intubation</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;</td><td rowspan="1" colspan="1">Between 3 and 5 days</td><td align="center" rowspan="1" colspan="1">12(50)</td><td align="center" rowspan="1" colspan="1">5(17.8)</td><td align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">Between 6 and 10 days</td><td align="center" rowspan="1" colspan="1">5(20.8)</td><td align="center" rowspan="1" colspan="1">14(50.0)</td><td align="center" rowspan="1" colspan="1">0.06</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td rowspan="1" colspan="1">&#x0003e;10 days</td><td align="center" rowspan="1" colspan="1">9(29.2)</td><td align="center" rowspan="1" colspan="1">7(32.2)</td><td align="center" rowspan="1" colspan="1">0.94</td></tr><tr><td colspan="2" rowspan="1">Duration of ICU stay (days)</td><td align="center" rowspan="1" colspan="1">11 [5-16]</td><td align="center" rowspan="1" colspan="1">12 [9-29]</td><td align="center" rowspan="1" colspan="1">0.36</td></tr><tr><td colspan="2" rowspan="1">Duration of hospital stay (days)</td><td align="center" rowspan="1" colspan="1">17 [11-23]</td><td align="center" rowspan="1" colspan="1">19 [9-34]</td><td align="center" rowspan="1" colspan="1">0.62</td></tr><tr><td colspan="2" rowspan="1">Mortality rate</td><td align="center" rowspan="1" colspan="1">9(37.5)</td><td align="center" rowspan="1" colspan="1">13(46.5)</td><td align="center" rowspan="1" colspan="1">0.07</td></tr></tbody></table><table-wrap-foot><fn><p>VAP - ventilator-associated pneumonia; ICU - Intensive care unit. Results are
expressed as the number (%) or median [25%-75%].</p></fn></table-wrap-foot></table-wrap><p>Tracheal aspirate cultures were collected from 38 patients (73%). The most commonly
identified bacteria were <italic>Pseudomonas aeruginosa, Klebsiella pneumoniae,
</italic>and <italic>Staphylococcus aureus </italic>(<xref ref-type="table" rid="t03">Table 3</xref>). The patient's oral conditions, evaluated using the plaque score,
are presented in <xref ref-type="table" rid="t04">table 4</xref>.</p><table-wrap id="t03" orientation="portrait" position="float"><label>Table 3</label><caption><p>Microbiological agents in the tracheal aspirate cultures of the placebo and 2%
chlorhexidine/toothbrushing groups</p></caption><table frame="hsides" rules="groups"><thead><tr><td rowspan="1" colspan="1"><bold>Agent</bold></td><td align="center" rowspan="1" colspan="1"><bold>Placebo</bold></td><td align="center" rowspan="1" colspan="1"><bold>Chlorhexidine</bold></td></tr></thead><tbody><tr><td rowspan="1" colspan="1"><italic>Pseudomonas aeruginosa</italic></td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td rowspan="1" colspan="1"><italic>Klebsiella pneumonia</italic></td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">4</td></tr><tr><td rowspan="1" colspan="1"><italic>Staphylococcus aureus</italic></td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">3</td></tr><tr><td rowspan="1" colspan="1"><italic>Acinetobacter baumannii</italic></td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td rowspan="1" colspan="1"><italic>Proteus mirabilis</italic></td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td></tr></tbody></table></table-wrap><table-wrap id="t04" orientation="portrait" position="float"><label>Table 4</label><caption><p>Data from oral-condition evaluations for the presence of bacterial plaque in all
patients during the first 24 hours in the intensive care unit</p></caption><table frame="hsides" rules="groups"><thead><tr><td rowspan="1" colspan="1"><bold>Degree</bold></td><td align="center" rowspan="1" colspan="1"><bold>Placebo</bold></td><td align="center" rowspan="1" colspan="1"><bold>Chlorhexidine</bold></td><td align="center" rowspan="1" colspan="1"><bold>p value</bold></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1"><bold>N(%)</bold></td><td align="center" rowspan="1" colspan="1"><bold>N(%)</bold></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">14(58.3)</td><td align="center" rowspan="1" colspan="1">15(53.5)</td><td align="center" rowspan="1" colspan="1">0.93</td></tr><tr><td rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">9(37.5)</td><td align="center" rowspan="1" colspan="1">11(39.2)</td><td align="center" rowspan="1" colspan="1">0.89</td></tr><tr><td rowspan="1" colspan="1">2 and 3</td><td align="center" rowspan="1" colspan="1">1(4.1)</td><td align="center" rowspan="1" colspan="1">2(7.1)</td><td align="center" rowspan="1" colspan="1">0.89</td></tr></tbody></table><table-wrap-foot><fn><p>Results are expressed as the number (%).</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>During the interim analysis of the present investigation of patients subjected to
prolonged intubation in a medical-surgical ICU, we were unable to evaluate the impact of
oral hygiene involving toothbrushing and 2% chlorhexidine gel application compared with
toothbrushing with placebo because the study was prematurely terminated due to
futility.</p><p>The results of this investigation are not consistent with the first double-blind
controlled study by DeRiso et al. regarding the use of 0.12% chlorhexidine in oral
hygiene to prevent nosocomial pneumonia in a homogeneous population of 353 patients
undergoing cardiovascular surgery. In that study, the researchers demonstrated a 69%
decrease in the incidence of nosocomial pneumonia.<sup>(<xref rid="r06" ref-type="bibr">6</xref>)</sup>
</p><p>Other studies performed in cardiac ICUs have yielded similar results. Houston et
al.<sup>(<xref rid="r15" ref-type="bibr">15</xref>)</sup> evaluated 561 patients
who underwent myocardial revascularization surgeries and determined a 58% decrease in
VAP rates using 0.12% chlorhexidine gluconate compared with oral hygiene using
Listerine.<sup>(<xref rid="r15" ref-type="bibr">15</xref>)</sup> Segers et al.
analyzed 954 patients undergoing cardiac surgery and observed a significant reduction in
respiratory tract infections after the preoperative application of 0.12% chlorhexidine
for oral hygiene compared with the placebo.<sup>(<xref rid="r16" ref-type="bibr">16</xref>)</sup>
</p><p>However, in heterogeneous, severely ill patient populations, the effect of chlorhexidine
use on nosocomial-pneumonia infection rates is controversial. One study using 0.2%
chlorhexidine for oral hygiene in critical patients demonstrated decreased pathogenic
colonization of the oral cavity and positive results for VAP prevention.<sup>(<xref rid="r17" ref-type="bibr">17</xref>)</sup> The same author published another
randomized, double-blind study using 0.2% chlorhexidine and observed that the number of
pathogens in the oral cavity decreased but not sufficiently to reduce the nosocomial
pneumonia rates.<sup>(<xref rid="r18" ref-type="bibr">18</xref>)</sup>
</p><p>Higher chlorhexidine concentrations, such as 2% chlorhexidine and 2% chlorhexidine with
colistin, were tested in critical patients and resulted in a 65% reduction of nosocomial
pneumonia cases in patients using 2% chlorhexidine and a 55% reduction in the group that
included the antibiotic.<sup>(<xref rid="r18" ref-type="bibr">18</xref>)</sup>
</p><p>Several meta-analyses have been published on this topic.<sup>(<xref rid="r09" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r20" ref-type="bibr">20</xref>)</sup> One randomized study followed by
meta-analysis was performed on a clinical-surgical ICU population using 2%
chlorhexidine, and the researchers concluded that oral decontamination by 2%
chlorhexidine is an effective and safe method for preventing VAP in this
population.<sup>(<xref rid="r09" ref-type="bibr">9</xref>)</sup> However, patients
in the study received mechanical ventilation for less than 48 hours, the randomization
process was not adequate (as the study was not blind), and at least one-half of the
included patients received mechanical ventilation for less than 48 hours, which was an
exclusion criterion in our study.</p><p>Pineda et al. analyzed 4 studies using chlorhexidine. In these investigations, different
concentrations of chlorhexidine and various patient populations were analyzed, and a
beneficial effect of chlorhexidine use was not observed.<sup>(<xref rid="r10" ref-type="bibr">10</xref>)</sup>
</p><p>A meta-analysis of 7 studies on antiseptic use for oral hygiene evaluated 2,144 patients
receiving mechanical ventilation (including cardiac and surgical patients) and found a
44% reduction in nosocomial pneumonia prevalence.<sup>(<xref rid="r19" ref-type="bibr">19</xref>)</sup> Another meta-analysis revealed benefits for a subgroup of
patients who had undergone mechanical ventilation for less than 48 hours, most of whom
had undergone cardiac surgery.<sup>(<xref rid="r20" ref-type="bibr">20</xref>)</sup> The
last meta-analysis of chlorhexidine use for oral hygiene in adult patients receiving
mechanical ventilation, which employed a fixed-effects model and moderate heterogeneity,
demonstrated a significant reduction of 25% in the VAP rate. Analysis of the subgroup
who underwent cardiac surgery revealed more favorable results for chlorhexidine, with a
reduction of greater than 50%.<sup>(<xref rid="r13" ref-type="bibr">13</xref>)</sup>
</p><p>Comparing data from these studies is difficult, as there was heterogeneity in these
meta-analyses, and various chlorhexidine concentrations, mechanical cleaning methods,
and populations were used. It is possible that the duration of intubation impeded
adequate cleaning of the oral cavity, in contrast with the cardiac surgery patients, who
are intubated for a short period, generally &#x0003c;48 hours.</p><p>In addition, more recent data has suggested that manual toothbrushing may not have any
effect or may even be detrimental. Munro et al.<sup>(<xref rid="r21" ref-type="bibr">21</xref>)</sup> demonstrated in a multicenter and factorial (2 x 2 design) study
conducted in clinical, surgical, and neurological ICUs that chlorhexidine without
brushing reduces the incidence of VAP and that brushing, whether alone or with
chlorhexidine, does not yield any benefit. Recently, Lorente et al.<sup>(<xref rid="r22" ref-type="bibr">22</xref>)</sup> randomized 436 patients for receiving
oral hygiene with or without manual brushing and concluded that brushing did not
decrease the incidence of VAP.</p><p>For intubated patients, manual brushing performed by a caregiver, rather than the
patient himselfl, might, contrary to expectations, increase the risk of adverse events
and the VAP rate, which would explain the high rates observed in both groups in our
study. It is also possible that toothbrushing causes bleeding gums and breaks the
mucosal barrier, thereby allowing pathogen invasion into the blood stream, releasing
additional bacteria from dental plaque (increasing the pathogenic load during
aspiration) or increasing the rate of accidental extubation-all of which are events
linked to VAP.<sup>(<xref rid="r22" ref-type="bibr">22</xref>)</sup> Furthermore,
toothbrushing without controlling the cuff pressure of the endotracheal tube before and
after hygiene (i.e., not ensuring the cuff seal) might increase the chance of
microaspiration. These data are consistent with the findings by Vieira et
al.,<sup>(<xref rid="r23" ref-type="bibr">23</xref>)</sup> who demonstrated in a
large number of patients that performing oral hygiene has a protective effect,
decreasing VAP rates by more than 50% but only when performed along with monitoring of
the pressure of the cuff. Failure to control the cuff pressure increased the risk by
60%.</p><p>It is clear that the oral cavity plays a fundamental role in colonization of the
oropharynx with nosocomial pathogens and that lack of oral hygiene compromises oral
immunity, facilitates biofilm formation, and/or causes loss of salivary
function.<sup>(<xref rid="r07" ref-type="bibr">7</xref>,<xref rid="r21" ref-type="bibr">21</xref>)</sup> However, it appears that oral hygiene involving 2%
chlorhexidine and toothbrushing alone does not prevent VAP in heterogeneous populations
of severely ill, intubated patients and thus should be performed in combination with
other preventative measures.<sup>(<xref rid="r10" ref-type="bibr">10</xref>)</sup> One
such set of preventative measures reduced pneumonia in 89.7% of the studied patients.
These measures were as follows: an oral hygiene protocol with suction toothbrushes and
0.12% chlorhexidine, increased hand antisepsis of the health professionals, daily
interruption of sedation, daily evaluation of extubation, prophylaxis against peptic
ulcers and venous thrombosis, and elevation of the head of the bed.<sup>(<xref rid="r01" ref-type="bibr">1</xref>)</sup>
</p><p>The most significant limitations of the present study were the small sample size and the
large number of patients who were excluded because they did not follow procedures. The
15% reduction in VAP absolute risk that was assumed when the sample size was calculated
might have been overly high, leading to underestimation of the number of patients
required for the planned analysis. Patients without adequate records of oral hygiene
procedures were excluded. These numbers suggest that evaluations of protocol adherence
and continued training should have been conducted throughout the study rather than only
at the beginning and the end.</p><p>Another significant limitation was the heterogeneity of the population. Other factors
should be controlled to identify the direct effect of chlorhexidine on the occurrence of
nosocomial pneumonia, including the characteristics of the primary pathology, patient
age, duration of hospital stay, and the absence or presence of teeth. Rigorous measures
for adherence to the oral hygiene protocol, type and frequency of application, and
quantity of gel used should also be performed. Moreover, in the present study, manual
brushing was used in both groups, despite insufficient evidence supporting its use in
intubated patients. Various techniques have been used in patients on ventilators, such
as humidified gases,<sup>(<xref rid="r12" ref-type="bibr">12</xref>,<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r22" ref-type="bibr">22</xref>)</sup> glove-protected hands,<sup>(<xref rid="r11" ref-type="bibr">11</xref>)</sup> cotton swabs,<sup>(<xref rid="r21" ref-type="bibr">21</xref>)</sup> manual toothbrushes,<sup>(<xref rid="r21" ref-type="bibr">21</xref>,<xref rid="r22" ref-type="bibr">22</xref>)</sup> electrical
toothbrushes,<sup>(<xref rid="r12" ref-type="bibr">12</xref>)</sup> and suction
toothbrushes.<sup>(<xref rid="r01" ref-type="bibr">1</xref>)</sup> To the best of
our knowledge, no data exist regarding the best oral-hygiene technique to employ, and
our results confirm the fact that more studies on this topic are necessary.</p><p>Patients receiving mechanical ventilation are unable to perform self-care; their
caregivers, in turn, may not have been adequately trained or instructed regarding the
importance of oral hygiene under these conditions.<sup>(<xref rid="r24" ref-type="bibr">24</xref>,<xref rid="r25" ref-type="bibr">25</xref>)</sup> In addition to
informing, encouraging, and continually training the patients' caregivers, it is likely
that hygienic measures that are overseen and performed by dental professionals would
have a greater impact, which should be evaluated in future studies.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Because the present study was prematurely interrupted due to futility, it was not
possible to evaluate the effect of employing 2% chlorhexidine and manual brushing for
oral hygiene on the incidence of VAP in this heterogeneous population of critically ill
patients receiving prolonged mechanical ventilation, and no benefits were observed for
this intervention.</p></sec></body><back><fn-group><fn id="fn01" fn-type="conflict"><p>
<bold>Conflicts of interest:</bold> None.</p></fn><fn id="fn02" fn-type="other"><p>This study was conducted at the Medical-Surgical Intensive Care Unit, Hospital de
Base de S&#x000e3;o Jos&#x000e9; do Rio Preto - S&#x000e3;o Jos&#x000e9; do Rio Preto (SP), Brazil.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r01"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutchins</surname><given-names>K</given-names></name><name><surname>Karras</surname><given-names>G</given-names></name><name><surname>Erwin</surname><given-names>J</given-names></name><name><surname>Sullivan</surname><given-names>KL</given-names></name></person-group><article-title>Ventilator-associated pneumonia and oral care: a successful quality
improvement project</article-title><source>Am J Infect Control</source><year>2009</year><volume>37</volume><issue>7</issue><fpage>590</fpage><lpage>597</lpage><pub-id pub-id-type="pmid">19716460</pub-id></element-citation></ref><ref id="r02"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacheco-Fowler</surname><given-names>V</given-names></name><name><surname>Gaonkar</surname><given-names>T</given-names></name><name><surname>Wyer</surname><given-names>PC</given-names></name><name><surname>Modak</surname><given-names>S</given-names></name></person-group><article-title>Antiseptic impregnated endotracheal tubes for the prevention of
bacterial colonization</article-title><source>J Hosp Infect</source><year>2004</year><volume>57</volume><issue>2</issue><fpage>170</fpage><lpage>174</lpage><pub-id pub-id-type="pmid">15183249</pub-id></element-citation></ref><ref id="r03"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American Thoracic Society</collab><collab>Infectious Diseases Society of America</collab></person-group><article-title>Guidelines for the management of adults with hospital-acquired,
ventilator-associated, and healthcare-associated pneumonia</article-title><source>Am J Respir Crit Care Med</source><year>2005</year><volume>171</volume><issue>4</issue><fpage>388</fpage><lpage>416</lpage><pub-id pub-id-type="pmid">15699079</pub-id></element-citation></ref><ref id="r04"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Sociedade Brasileira de Pneumologia e Tisiologia</collab><collab>Comiss&#x000e3;o de Infec&#x000e7;&#x000f5;es Respirat&#x000f3;rias e Micoses pulmonares</collab></person-group><article-title xml:lang="pt">Diretrizes brasileiras para tratamento das pneumonias
adquiridas no hospital e das associadas &#x000e0; ventila&#x000e7;&#x000e3;o mec&#x000e2;nica -
2007</article-title><source>J Bras Pneumol</source><year>2007</year><volume>33</volume><issue>Supl 1</issue><fpage>S1</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">18833653</pub-id></element-citation></ref><ref id="r05"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alp</surname><given-names>E</given-names></name><name><surname>Voss</surname><given-names>A</given-names></name></person-group><article-title>Ventilator associated pneumonia and infection control</article-title><source>Ann Clin Microbiol Antimicrob</source><year>2006</year><volume>5</volume><fpage>7</fpage><pub-id pub-id-type="pmid">16600048</pub-id></element-citation></ref><ref id="r06"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeRiso 2nd</surname><given-names>AJ</given-names></name><name><surname>Ladowsky</surname><given-names>JS</given-names></name><name><surname>Dillon</surname><given-names>TA</given-names></name><name><surname>Justice</surname><given-names>JW</given-names></name><name><surname>Peterson</surname><given-names>AC</given-names></name></person-group><article-title>Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of
total nosocomial respiratory infection and nonprophylactic systemic antibiotic use
in patients undergoing heart surgery</article-title><source>Chest</source><year>1996</year><volume>109</volume><issue>6</issue><fpage>1556</fpage><lpage>1561</lpage><pub-id pub-id-type="pmid">8769511</pub-id></element-citation></ref><ref id="r07"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagata</surname><given-names>E</given-names></name><name><surname>de Toledo</surname><given-names>A</given-names></name><name><surname>Oho</surname><given-names>T</given-names></name></person-group><article-title>Invasion of human aortic endothelial cells by oral viridans group
streptococci and induction of inflammatory cytokine production</article-title><source>Mol Oral Microbiol</source><year>2011</year><volume>26</volume><issue>1</issue><fpage>78</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">21214874</pub-id></element-citation></ref><ref id="r08"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scannapieco</surname><given-names>FA</given-names></name><name><surname>Bush</surname><given-names>RB</given-names></name><name><surname>Paju</surname><given-names>S</given-names></name></person-group><article-title>Associations between periodontal disease and risk for nosocomial
bacterial pneumonia and chronic obstructive pulmonary disease. A systematic
review</article-title><source>Ann Periodontol</source><year>2003</year><volume>8</volume><issue>1</issue><fpage>54</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">14971248</pub-id></element-citation></ref><ref id="r09"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tantipong</surname><given-names>H</given-names></name><name><surname>Morkchareonpong</surname><given-names>C</given-names></name><name><surname>Jaiyindee</surname><given-names>S</given-names></name><name><surname>Thamlikitkul</surname><given-names>V</given-names></name></person-group><article-title>Randomized controlled trial and meta-analysis of oral decontamination
with 2% chlorhexidine solution for the prevention of ventilator-associated
pneumonia</article-title><source>Infect Control Hosp Epidemiol</source><year>2008</year><volume>29</volume><issue>2</issue><fpage>131</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">18179368</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pineda</surname><given-names>LA</given-names></name><name><surname>Saliba</surname><given-names>RG</given-names></name><name><surname>El Solh</surname><given-names>AA</given-names></name></person-group><article-title>Effect of oral decontamination with chlorhexidine on the incidence of
nosocomial pneumonia: a meta-analysis</article-title><source>Crit Care</source><year>2006</year><volume>10</volume><issue>1</issue><fpage>R35</fpage><pub-id pub-id-type="pmid">16507165</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fourrier</surname><given-names>F</given-names></name><name><surname>Dubois</surname><given-names>D</given-names></name><name><surname>Pronier</surname><given-names>P</given-names></name><name><surname>Herbecq</surname><given-names>P</given-names></name><name><surname>Leroy</surname><given-names>O</given-names></name><name><surname>Desmettre</surname><given-names>T</given-names></name><name><surname>Pottier-Cau</surname><given-names>E</given-names></name><name><surname>Boutigny</surname><given-names>H</given-names></name><name><surname>Di Pomp&#x000e9;o</surname><given-names>C</given-names></name><name><surname>Durocher</surname><given-names>A</given-names></name><name><surname>Roussel-Delvallez</surname><given-names>M</given-names></name><collab>PIRAD Study Group</collab></person-group><article-title>Effect of gingival and dental plaque antiseptic decontamination on
nosocomial infections acquired in the intensive care unit: a double-blind
placebo-controlled multicenter study</article-title><source>Crit Care Med</source><year>2005</year><volume>33</volume><issue>8</issue><fpage>1728</fpage><lpage>1735</lpage><pub-id pub-id-type="pmid">16096449</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pobo</surname><given-names>A</given-names></name><name><surname>Lisboa</surname><given-names>T</given-names></name><name><surname>Rodriguez</surname><given-names>A</given-names></name><name><surname>Sole</surname><given-names>R</given-names></name><name><surname>Magret</surname><given-names>M</given-names></name><name><surname>Trefler</surname><given-names>S</given-names></name><name><surname>G&#x000f3;mez</surname><given-names>F</given-names></name><name><surname>Rello</surname><given-names>J</given-names></name><collab>RASPALL Study Investigators</collab></person-group><article-title>A randomized trial of dental brushing for preventing
ventilator-associated pneumonia</article-title><source>Chest</source><year>2009</year><volume>136</volume><issue>2</issue><fpage>433</fpage><lpage>439</lpage><pub-id pub-id-type="pmid">19482956</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chlebicki</surname><given-names>MP</given-names></name><name><surname>Safdar</surname><given-names>N</given-names></name></person-group><article-title>Topical chlorhexidine for prevention of ventilador-associated
pneumonia: a meta-analysis</article-title><source>Crit Care Med</source><year>2007</year><volume>35</volume><issue>2</issue><fpage>595</fpage><lpage>602</lpage><pub-id pub-id-type="pmid">17205028</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silness</surname><given-names>J</given-names></name><name><surname>Loe</surname><given-names>H</given-names></name></person-group><article-title>Periodontal disease in pregnancy. II. Correlation between oral hygiene
and periodontal condition</article-title><source>Acta Odontol Scand</source><year>1964</year><volume>22</volume><fpage>121</fpage><lpage>135</lpage><pub-id pub-id-type="pmid">14158464</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houston</surname><given-names>S</given-names></name><name><surname>Hougland</surname><given-names>P</given-names></name><name><surname>Anderson</surname><given-names>JJ</given-names></name><name><surname>LaRocco</surname><given-names>M</given-names></name><name><surname>Kennedy</surname><given-names>V</given-names></name><name><surname>Gentry</surname><given-names>LO</given-names></name></person-group><article-title>Effectiveness of 0,12% chlorhexidine gluconate oral rinse in reducing
prevalence of nosocomial pneumonia in patients undergoing heart
surgery</article-title><source>Am J Crit Care</source><year>2002</year><volume>11</volume><issue>6</issue><fpage>567</fpage><lpage>570</lpage><pub-id pub-id-type="pmid">12425407</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segers</surname><given-names>P</given-names></name><name><surname>Speekenbrink</surname><given-names>RG</given-names></name><name><surname>Ubbink</surname><given-names>DT</given-names></name><name><surname>van Ogtrop</surname><given-names>ML</given-names></name><name><surname>de Mol</surname><given-names>BA</given-names></name></person-group><article-title>Prevention of nocomial infection in cardiac surgery by decontamination
of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized
controlled trial</article-title><source>JAMA</source><year>2006</year><volume>296</volume><issue>20</issue><fpage>2460</fpage><lpage>2466</lpage><pub-id pub-id-type="pmid">17119142</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fourrier</surname><given-names>F</given-names></name><name><surname>Cau-Pottier</surname><given-names>E</given-names></name><name><surname>Boutigny</surname><given-names>H</given-names></name><name><surname>Roussel-Delvelles</surname><given-names>M</given-names></name><name><surname>Jourdain</surname><given-names>M</given-names></name><name><surname>Chopin</surname><given-names>C</given-names></name></person-group><article-title>Effects of dental plaque antiseptic decontamination on bacterial
colonization and nosocomial infections in critically ill patients</article-title><source>Intensive Care Med</source><year>2000</year><volume>26</volume><issue>9</issue><fpage>1239</fpage><lpage>1247</lpage><pub-id pub-id-type="pmid">11089748</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koeman</surname><given-names>M</given-names></name><name><surname>van der Ven</surname><given-names>AJ</given-names></name><name><surname>Hak</surname><given-names>E</given-names></name><name><surname>Joore</surname><given-names>HC</given-names></name><name><surname>Kaasjager</surname><given-names>K</given-names></name><name><surname>de Smet</surname><given-names>AG</given-names></name><etal>et al</etal></person-group><article-title>Oral decontamination with chlorhexidine reduces the incidence of
ventilator-associated pneumonia</article-title><source>Am J Respir Crit Care Med</source><year>2006</year><volume>173</volume><issue>12</issue><fpage>1348</fpage><lpage>1355</lpage><pub-id pub-id-type="pmid">16603609</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>EY</given-names></name><name><surname>Ruest</surname><given-names>A</given-names></name><name><surname>Meade</surname><given-names>OM</given-names></name><name><surname>Cook</surname><given-names>DJ</given-names></name></person-group><article-title>Oral decontamition for prevention of pneumonia in mechanically
ventilated adults: systematic review and meta-analysis</article-title><source>BMJ</source><year>2007</year><volume>334</volume><issue>7599</issue><fpage>889</fpage><lpage>889</lpage><comment>Review</comment><pub-id pub-id-type="pmid">17387118</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kola</surname><given-names>A</given-names></name><name><surname>Gastmeier</surname><given-names>P</given-names></name></person-group><article-title>Efficacy of oral chlorhexidine preventing lower respiratory tract
infections. Meta-analysis of randomized controlled trials</article-title><source>J Hosp Infect</source><year>2007</year><volume>66</volume><issue>3</issue><fpage>207</fpage><lpage>216</lpage><pub-id pub-id-type="pmid">17544168</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munro</surname><given-names>CL</given-names></name><name><surname>Grap</surname><given-names>MJ</given-names></name><name><surname>Jones</surname><given-names>DJ</given-names></name><name><surname>McClish</surname><given-names>DK</given-names></name><name><surname>Sessler</surname><given-names>CN</given-names></name></person-group><article-title>Chlorhexidine, toothbrushing, and preventing ventilator-associated
pneumonia in critically ill adults</article-title><source>Am J Crit Care</source><year>2009</year><volume>18</volume><issue>5</issue><fpage>428</fpage><lpage>437</lpage><pub-id pub-id-type="pmid">19723863</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorente</surname><given-names>L</given-names></name><name><surname>Lecuona</surname><given-names>M</given-names></name><name><surname>Jim&#x000e9;nez</surname><given-names>A</given-names></name><name><surname>Palmero</surname><given-names>S</given-names></name><name><surname>Pastor</surname><given-names>E</given-names></name><name><surname>Lafuente</surname><given-names>N</given-names></name><name><surname>Ramos</surname><given-names>MJ</given-names></name><name><surname>Mora</surname><given-names>ML</given-names></name><name><surname>Sierra</surname><given-names>A</given-names></name></person-group><article-title>Ventilator-associated pneumonia with or without tooth brushing: a
randomized controlled trial</article-title><source>Eur J Clin Microbiol Infect Dis</source><year>2012</year><volume>31</volume><fpage>2621</fpage><lpage>2629</lpage><pub-id pub-id-type="pmid">22422274</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuanazzi</surname><given-names>D</given-names></name><name><surname>Souto</surname><given-names>R</given-names></name><name><surname>Mattos</surname><given-names>MB</given-names></name><name><surname>Zuanazzi</surname><given-names>MR</given-names></name><name><surname>Tura</surname><given-names>BR</given-names></name><name><surname>Sansone</surname><given-names>C</given-names></name><etal>et al</etal></person-group><article-title>Prevalence of potential bacterial respiratory pathogens in the oral
cavity of hospitalised individuals</article-title><source>Arch Oral Biol</source><year>2010</year><volume>55</volume><issue>1</issue><fpage>21</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">19939349</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Vieira</surname><given-names>DF</given-names></name></person-group><source xml:lang="pt">Implanta&#x000e7;&#x000e3;o de protocolo de preven&#x000e7;&#x000e3;o da pneumonia associada &#x000e0;
ventila&#x000e7;&#x000e3;o mec&#x000e2;nica: impacto do cuidado n&#x000e3;o farmacol&#x000f3;gico [tese]</source><publisher-loc>Rio Grande do Sul</publisher-loc><publisher-name>Faculdade de Medicina da Universidade Federal do Rio Grande do
Sul</publisher-name><year>2009</year></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salomao</surname><given-names>R</given-names></name><name><surname>Rosenthal</surname><given-names>VD</given-names></name><name><surname>Grimberg</surname><given-names>G</given-names></name><name><surname>Nouer</surname><given-names>S</given-names></name><name><surname>Blecher</surname><given-names>S</given-names></name><name><surname>Buchner-Ferreira</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>Device-associated infection rates in intensive care units of Brazilian
hospitals: findings of the International Nosocomial Infection Control
Consortium</article-title><source>Rev Panam Salud Publica</source><year>2008</year><volume>24</volume><issue>3</issue><fpage>195</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">19115547</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brito</surname><given-names>LF</given-names></name><name><surname>Vargas</surname><given-names>MA</given-names></name><name><surname>Leal</surname><given-names>SM</given-names></name></person-group><article-title xml:lang="pt">Higiene oral em pacientes no estado de s&#x000ed;ndrome do
d&#x000e9;ficit no autocuidado</article-title><source>Rev Ga&#x000fa;ch Enferm</source><year>2007</year><volume>28</volume><issue>3</issue><fpage>359</fpage><lpage>367</lpage></element-citation></ref></ref-list></back></article>